305 related articles for article (PubMed ID: 19579589)
1. Length of vancomycin administration for treatment of clostridium difficile-associated diarrhea may depend on presentation of colonic ulcer.
Yamashita M; Nomura K; Fujimoto Y; Morimoto Y; Ohshiro M; Tsutsumi Y; Kobayashi T; Kaneko H; Yasuhawa S; Yanagisawa A; Toshikazu Y; Masafumi T;
Hepatogastroenterology; 2009; 56(90):313-6. PubMed ID: 19579589
[TBL] [Abstract][Full Text] [Related]
2. Absence of pseudomembranes in Clostridium difficile-associated diarrhea in patients using immunosuppression agents.
Nomura K; Fujimoto Y; Yamashita M; Morimoto Y; Ohshiro M; Sato K; Oyake T; Kowata S; Konishi H; Yoshikawa T; Ishida Y; Taniwaki M;
Scand J Gastroenterol; 2009; 44(1):74-8. PubMed ID: 18781540
[TBL] [Abstract][Full Text] [Related]
3. Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin.
Al-Nassir WN; Sethi AK; Nerandzic MM; Bobulsky GS; Jump RL; Donskey CJ
Clin Infect Dis; 2008 Jul; 47(1):56-62. PubMed ID: 18491964
[TBL] [Abstract][Full Text] [Related]
4. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity.
Zar FA; Bakkanagari SR; Moorthi KM; Davis MB
Clin Infect Dis; 2007 Aug; 45(3):302-7. PubMed ID: 17599306
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027.
Pépin J; Valiquette L; Gagnon S; Routhier S; Brazeau I
Am J Gastroenterol; 2007 Dec; 102(12):2781-8. PubMed ID: 17900327
[TBL] [Abstract][Full Text] [Related]
6. The diagnosis and treatment of Clostridium difficile in antibiotic-associated diarrhea.
Gorenek L; Dizer U; Besirbellioglu B; Eyigun CP; Hacibektasoglu A; Van Thiel DH
Hepatogastroenterology; 1999; 46(25):343-8. PubMed ID: 10228818
[TBL] [Abstract][Full Text] [Related]
7. Clostridium difficile-associated diarrhea with hematochezia is associated with ulcer formation.
Morimoto Y; Nomura K; Tsutsumi Y; Ohshiro M; Fujimoto Y; Shimizu D; Wakabayashi N; Konishi H; Mitsufuji S; Matsumoto Y; Taniwaki M
Scand J Gastroenterol; 2008 Aug; 43(8):967-70. PubMed ID: 19086279
[TBL] [Abstract][Full Text] [Related]
8. Resolution of recurrent Clostridium difficile-associated diarrhea using staggered antibiotic withdrawal and kefir.
Bakken JS
Minn Med; 2009 Jul; 92(7):38-40. PubMed ID: 19708314
[TBL] [Abstract][Full Text] [Related]
9. Management and outcomes of a first recurrence of Clostridium difficile-associated disease in Quebec, Canada.
Pépin J; Routhier S; Gagnon S; Brazeau I
Clin Infect Dis; 2006 Mar; 42(6):758-64. PubMed ID: 16477549
[TBL] [Abstract][Full Text] [Related]
10. [Diarrhea due to Clostridium difficile toxin in hemato-oncological patients].
Kerst JM; van der Lelie J; Kuijper EJ
Ned Tijdschr Geneeskd; 2001 Jun; 145(24):1137-40. PubMed ID: 11433658
[TBL] [Abstract][Full Text] [Related]
11. Clostridium difficile-associated disease with lethal outcome in a 77-year-old woman. A case report.
Pekova L; Shomov G; Mladenova I; Pellicano R
Minerva Gastroenterol Dietol; 2007 Dec; 53(4):383-6. PubMed ID: 18043555
[TBL] [Abstract][Full Text] [Related]
12. Proton pump inhibitor use and recurrent Clostridium difficile-associated disease: a case-control analysis matched by propensity score.
Kim YG; Graham DY; Jang BI
J Clin Gastroenterol; 2012; 46(5):397-400. PubMed ID: 22298089
[TBL] [Abstract][Full Text] [Related]
13. Intravenous immunoglobulin for the treatment of severe, refractory, and recurrent Clostridium difficile diarrhea.
McPherson S; Rees CJ; Ellis R; Soo S; Panter SJ
Dis Colon Rectum; 2006 May; 49(5):640-5. PubMed ID: 16525744
[TBL] [Abstract][Full Text] [Related]
14. Treatment strategies for C. difficile associated diarrhea.
Stepan C; Surawicz CM
Acta Gastroenterol Latinoam; 2007 Sep; 37(3):183-91. PubMed ID: 17955730
[TBL] [Abstract][Full Text] [Related]
15. [Percutaneous endoscopic colostomy for treatment of an antibiotic-induced pseudomembranous colitis].
Prassler R
Dtsch Med Wochenschr; 2008 Oct; 133(44):2268-71. PubMed ID: 18946851
[TBL] [Abstract][Full Text] [Related]
16. Incidence of Clostridium difficile-associated diarrhea before and after autologous peripheral blood stem cell transplantation for lymphoma and multiple myeloma.
Arango JI; Restrepo A; Schneider DL; Callander NS; Ochoa-Bayona JL; Restrepo MI; Bradshaw P; Patterson J; Freytes CO
Bone Marrow Transplant; 2006 Mar; 37(5):517-21. PubMed ID: 16435018
[TBL] [Abstract][Full Text] [Related]
17. The changing face of Clostridium difficile: what treatment options remain?
Shen EP; Surawicz CM
Am J Gastroenterol; 2007 Dec; 102(12):2789-92. PubMed ID: 18042108
[TBL] [Abstract][Full Text] [Related]
18. Association of interleukin-8 polymorphism and immunoglobulin G anti-toxin A in patients with Clostridium difficile-associated diarrhea.
Jiang ZD; Garey KW; Price M; Graham G; Okhuysen P; Dao-Tran T; LaRocco M; DuPont HL
Clin Gastroenterol Hepatol; 2007 Aug; 5(8):964-8. PubMed ID: 17618838
[TBL] [Abstract][Full Text] [Related]
19. [Relapsing infections with Clostridium difficile].
Visser WE; Dingemans-Dumas AM; Bac DJ
Ned Tijdschr Geneeskd; 2005 Oct; 149(43):2381-5. PubMed ID: 16277125
[TBL] [Abstract][Full Text] [Related]
20. Past, present, and future therapies for Clostridium difficile-associated disease.
Surowiec D; Kuyumjian AG; Wynd MA; Cicogna CE
Ann Pharmacother; 2006 Dec; 40(12):2155-63. PubMed ID: 17148650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
